Effect of palivizumab prophylaxis in decreasing respiratory syncytial virus hospitalizations in premature infants

Abstract

Data from this study support the effectiveness of palivizumab in significantly modifying RSV-related hospitalizations in high risk preterm infants, with and without CLD, during two respiratory seasons.